subject: UMLS:C2698144

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: bariatric surgery candidate

tested_intervention: unsure


subject: UMLS:C1099192


subject: UMLS:C1099192

object_name: morbid obesity


subject: UMLS:C2976285

subject_name: TAK 438

object_name: duodenal ulcer


subject: CHEBI:136048

subject_name: Vonoprazan


subject: CHEBI:10119

subject_name: Ziprasidone

object_name: post-traumatic stress disorder

tested_intervention: yes


subject: CHEBI:7565

subject_name: Nifedipine

object_name: Severe pre-eclampsia, antepartum condition or complication


subject: PUBCHEM.COMPOUND:15602265

subject_name: Ganoderiol F


subject: PUBCHEM.COMPOUND:15602265

object_name: Pneumonia caused by SARS-CoV-2


subject: PUBCHEM.COMPOUND:15602265

object_name: COVID-19 respiratory infection


subject: PUBCHEM.COMPOUND:15602265

object_name: Acute respiratory distress syndrome due to COVID-19


subject: CHEBI:3440

subject_name: Carvacrol


subject: CHEBI:3440


subject: CHEBI:3440


subject: CHEBI:3440


subject: PUBCHEM.COMPOUND:4056

subject_name: vitamin K2

object_name: Arterial Stiffness


subject: PUBCHEM.COMPOUND:4056

object_name: migraine


subject: UNII:71ANL51TLA

subject_name: Menaquinone 6


subject: UNII:71ANL51TLA


subject: PUBCHEM.COMPOUND:14236712

subject_name: Withanolide B


subject: PUBCHEM.COMPOUND:14236712


subject: PUBCHEM.COMPOUND:5280374


subject: PUBCHEM.COMPOUND:5280374


subject: CHEBI:28869

subject_name: Menadione


subject: CHEBI:28869


subject: UNII:12V8PA4WCH

subject_name: Menaquinone


subject: UNII:12V8PA4WCH


subject: CHEBI:16374

subject_name: Menatetrenone


subject: CHEBI:16374


subject: PUBCHEM.COMPOUND:75038


subject: PUBCHEM.COMPOUND:75038


subject: CHEBI:44245

subject_name: Menaquinone 7


subject: CHEBI:44245


subject: UMLS:C2716079

subject_name: Polyoxidonium

object_name: Coronavinae infectious disease


subject: CHEBI:33357

subject_name: hassium atom

object_name: cystic fibrosis


subject: CHEBI:74056

subject_name: His-Ser


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Childhood Breast Carcinoma


subject: CHEBI:25681

object_name: breast carcinoma


subject: CHEBI:25681

object_name: breast cancer


subject: CHEBI:25681

object_name: Arthralgia


subject: CHEBI:25681

object_name: Arthralgia, CTCAE


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]


subject: UMLS:C3536908


subject: UMLS:C3536908


subject: UMLS:C3536908


subject: UMLS:C3536908


subject: UMLS:C2364569

subject_name: rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain

object_name: Rotavirus infection


subject: CHEBI:2663

subject_name: Amiodarone

object_name: cardiomyopathy


subject: CHEBI:2663

object_name: Ventricular premature beats, contractions, or systoles


subject: UMLS:C0003195

subject_name: Anti-Arrhythmia Agents


subject: UMLS:C0003195


subject: PUBCHEM.COMPOUND:56932509

object_name: hepatitis C


subject: PUBCHEM.COMPOUND:56932509

object_name: chronic hepatitis C virus infection


subject: CHEBI:37924

subject_name: Atazanavir


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:71219

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:71219

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:71219

object_name: Renal cell carcinoma recurrent


subject: CHEBI:71219

object_name: Renal cancer recurrent


subject: CHEBI:145499

subject_name: Donepezil

object_name: Radiation Sickness


subject: CHEBI:145499

object_name: cognitive/functional effects


subject: CHEBI:145499

object_name: Long-Term Effects Secondary to Cancer Therapy in Children


subject: CHEBI:145499

object_name: psychosocial effects of cancer and its treatment


subject: CHEBI:145499

object_name: neurotoxicity


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic

object_name: Atelectasis


subject: MESH:D012462

object_name: Atelectasis, CTCAE


subject: UMLS:C1611640

subject_name: Therapeutic agent (substance)

object_name: pancreatic neoplasm


subject: UMLS:C1611640

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1611640

object_name: malignant pancreatic neoplasm


subject: CHEBI:72323

subject_name: Alogliptin

object_name: diabetes mellitus


subject: CHEBI:231678

subject_name: Evofosfamide

object_name: glioblastoma


subject: CHEBI:231678

object_name: Childhood Glioblastoma


subject: CHEBI:231678

object_name: adult glioblastoma


subject: CHEBI:31687

subject_name: Idebenone

object_name: Parkinson disease


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:233362

object_name: Epithelioma


subject: UNII:3DGD69C6PV

subject_name: brigatinib


subject: UNII:3DGD69C6PV

object_name: Advanced cancer


subject: UNII:3DGD69C6PV


subject: CHEBI:78432

subject_name: Ceritinib


subject: CHEBI:78432


subject: CHEBI:78432


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: CHEBI:23359

subject_name: colchicine


subject: CHEBI:23359


subject: CHEBI:23359


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:61397

subject_name: Neratinib


subject: CHEBI:61397


subject: CHEBI:61397


subject: CHEBI:78543

subject_name: Ponatinib


subject: CHEBI:78543


subject: CHEBI:78543


subject: CHEBI:229764

subject_name: Selinexor


subject: CHEBI:229764


subject: CHEBI:42588

subject_name: Fenretinide

object_name: myeloproliferative neoplasm


subject: CHEBI:42588

object_name: adult lymphoma


subject: CHEBI:42588

object_name: lymphoma


subject: CHEBI:42588

object_name: pediatric lymphoma


subject: CHEBI:42588

object_name: leukemia


subject: CHEBI:42588

object_name: childhood leukemia


subject: CHEBI:49868

object_name: endometrial cancer


subject: CHEBI:49868

object_name: uterine corpus cancer


subject: CHEBI:49868

object_name: endometrial carcinoma


subject: CHEBI:49868

object_name: Neck Carcinoma


subject: CHEBI:49868

object_name: head and neck neoplasm


subject: CHEBI:49868

object_name: head and neck cancer


subject: CHEBI:49868

object_name: ovarian cancer


subject: CHEBI:49868

object_name: ovarian neoplasm


subject: CHEBI:49868

object_name: ovarian carcinoma


subject: CHEBI:49868

object_name: Childhood Breast Carcinoma


subject: CHEBI:49868

object_name: breast carcinoma


subject: CHEBI:49868

object_name: breast cancer


subject: CHEBI:49868

object_name: skin melanoma


subject: CHEBI:49868

object_name: malignant soft tissue neoplasm


subject: CHEBI:49868

object_name: sarcoma


subject: UNII:CVN0S9V910

subject_name: MAL

object_name: Photodamaged skin


subject: UNII:CVN0S9V910

object_name: actinic keratosis


subject: CHEBI:15595


subject: CHEBI:15595


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Acute Pain


subject: CHEBI:85252

subject_name: synaptamide

object_name: primary ovarian failure


subject: CHEBI:85252

object_name: premature menopause


subject: CHEBI:89608

subject_name: Cervonoyl ethanolamide


subject: CHEBI:89608


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Inflammation


subject: CHEBI:71416

subject_name: phenazopyridine

object_name: Urinary Retention


subject: CHEBI:71416

object_name: Urinary Retention, CTCAE


subject: PUBCHEM.COMPOUND:135580740

subject_name: Phenazo


subject: PUBCHEM.COMPOUND:135580740


subject: UNII:K2J09EMJ52

subject_name: Phenazopyridine


subject: UNII:K2J09EMJ52


subject: CHEBI:7772

subject_name: omeprazole

object_name: esophagitis


subject: CHEBI:7772

object_name: Esophagitis, CTCAE


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: UMLS:C0962969

subject_name: RAD 001

object_name: tuberous sclerosis


subject: UMLS:C0962969

object_name: situs inversus


subject: UMLS:C0962969

object_name: lymphangioleiomyomatosis


subject: UMLS:C0962969

object_name: lung lymphangioleiomyomatosis


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: UMLS:C1721789

subject_name: Cervarix

object_name: human papilloma virus infection


subject: UNII:WTT295HSY5

subject_name: Dulaglutide


subject: UMLS:C2976495


subject: CHEBI:75431

subject_name: ghrelin

object_name: major depressive disorder


subject: DRUGBANK:DB11895

subject_name: Lenomorelin


subject: UMLS:C0911014


subject: CHEBI:17992

subject_name: Sucrose

object_name: Pain, Procedural


subject: UMLS:C5882212

object_name: type 2 diabetes mellitus


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Tinnitus


subject: CHEBI:41879

object_name: Tinnitus, CTCAE 5.0


subject: CHEBI:41879

object_name: Tinnitus, CTCAE 3.0


subject: UMLS:C5853662

object_name: melanoma


subject: CHEBI:27470

subject_name: Folic acid

object_name: male infertility


subject: CHEBI:27470

object_name: inability to impregnate


subject: DRUGBANK:DB17772

subject_name: Remune

object_name: HIV infection


subject: MESH:C078788

subject_name: ALVAC vaccine


subject: UNII:ZXM835LQ5E

subject_name: Uprosertib


subject: UMLS:C2830127


subject: UMLS:C2703095


subject: UMLS:C1725733

subject_name: ACB (Acebutolol)

object_name: Postoperative Pain, Acute


subject: CHEBI:64816

object_name: brain neoplasm


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:38215

subject_name: calcium channel blocker

object_name: hypertension


subject: CHEBI:38215

object_name: Hypertension, CTCAE


subject: CHEBI:38215


subject: UMLS:C0006684

subject_name: Calcium Channel Blockers


subject: UMLS:C0006684


subject: UMLS:C0006684


subject: MESH:D049971

subject_name: Thiazides


subject: MESH:D049971


subject: MESH:D049971


subject: CHEBI:50264

subject_name: thiazide


subject: CHEBI:50264


subject: CHEBI:50264


subject: CHEBI:41423

subject_name: Celecoxib

object_name: central nervous system embryonal neoplasm


subject: CHEBI:41423

object_name: central nervous system primitive neuroectodermal neoplasm


subject: CHEBI:41423

object_name: Central Nervous System Embryonal Tumor with Rhabdoid Features


subject: CHEBI:41423

object_name: ependymoblastoma


subject: CHEBI:41423

object_name: embryonal tumor with multilayered rosettes


subject: CHEBI:41423

object_name: atypical teratoid rhabdoid tumor


subject: CHEBI:41423

object_name: childhood medulloblastoma


subject: CHEBI:41423

object_name: medulloblastoma non-WNT/non-SHH group 4


subject: CHEBI:41423

object_name: medulloblastoma non-WNT/non-SHH group 3


subject: CHEBI:41423

object_name: medulloblastoma


subject: CHEBI:41423

object_name: medulloepithelioma


subject: CHEBI:41423

object_name: Childhood Neuroblastoma


subject: CHEBI:41423

object_name: neuroblastoma


subject: CHEBI:41423

object_name: Childhood Pineoblastoma


subject: CHEBI:41423

object_name: pineoblastoma


subject: CHEBI:41423

object_name: adult pineoblastoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:6067

subject_name: Isotretinoin


subject: CHEBI:6067


subject: CHEBI:6067


subject: CHEBI:6067


subject: CHEBI:6067


subject: CHEBI:6067


subject: CHEBI:6067


subject: CHEBI:6067


subject: CHEBI:6067


subject: CHEBI:6067


subject: CHEBI:6067


subject: CHEBI:6067


subject: CHEBI:6067


subject: CHEBI:6067


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:41774

subject_name: Tamoxifen


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:6801

subject_name: Metformin

object_name: Tyrosine kinase mutation


subject: CHEBI:6801

object_name: EGFR gene mutation


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: esophageal squamous cell carcinoma


subject: CHEBI:31355


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Primary malignant neoplasm of hypopharynx


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UNII:YI437801BE

subject_name: Mogamulizumab

object_name: Mycosis fungoides/Sezary syndrome


subject: UMLS:C1831941


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UNII:DPT0O3T46P

object_name: primary cutaneous T-cell lymphoma


subject: UNII:DPT0O3T46P


subject: CHEBI:85083

subject_name: Sofosbuvir

object_name: severe acute respiratory syndrome


subject: CHEBI:82977

subject_name: Daclatasvir


subject: CHEBI:16796

subject_name: Melatonin

object_name: Post-Operative Pain


subject: CHEBI:10125

subject_name: Zolpidem

object_name: endometrium neoplasm


subject: UMLS:C0879430

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C0879430

object_name: clear cell renal carcinoma


subject: UMLS:C0879430

object_name: renal cell adenocarcinoma


subject: UMLS:C0879430

object_name: renal cell carcinoma


subject: CHEBI:63605

subject_name: Ixabepilone


subject: CHEBI:63605


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: UNII:884KT10YB7

subject_name: (Z)-ranitidine


subject: UNII:884KT10YB7


subject: UNII:884KT10YB7


subject: UNII:884KT10YB7


subject: CHEBI:8776

subject_name: ranitidine


subject: CHEBI:8776


subject: CHEBI:8776


subject: CHEBI:8776


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Cognition - other


subject: UMLS:C1955477

subject_name: Glucose (oral)

object_name: esophageal atresia


subject: UMLS:C1955477

object_name: dumping syndrome


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: rheumatoid arthritis


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: GTOPDB:2943

subject_name: secretin

object_name: chronic pancreatitis


subject: CHEBI:232390


subject: CHEBI:6402

subject_name: Leflunomide

object_name: HIV infection


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: type 1 diabetes mellitus 1


subject: CHEBI:144903

object_name: type 1 diabetes mellitus


subject: CHEBI:61848


subject: CHEBI:61848


subject: PR:000013192


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: UniProtKB:P05142


subject: PR:000013551


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: PR:000003551


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: UniProtKB:P67986


subject: PR:000001886

subject_name: major prion protein


subject: PR:000001886


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000030465


subject: PR:000013555

subject_name: proline-rich protein 2


subject: PR:000013555


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: UniProtKB:P05143


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PR:000032963


subject: UMLS:C3819106

subject_name: Pedia-Lax Probiotic

object_name: Allergy


subject: UMLS:C3819106

object_name: History of allergies


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS


subject: UNII:71M78END5S


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: UMLS:C3853942

object_name: Childhood Breast Carcinoma


subject: UMLS:C3853942

object_name: breast carcinoma


subject: UMLS:C3853942

object_name: breast cancer


subject: UMLS:C3853942

object_name: Breast adenocarcinoma metastatic


subject: CHEMBL.COMPOUND:CHEMBL1200571

subject_name: GADOBENATE DIMEGLUMINE

object_name: colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: colorectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: Metastatic malignant neoplasm to liver


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: Oligometastatic malignant neoplasm


subject: UNII:3Q6PPC19PO


subject: UNII:3Q6PPC19PO


subject: UNII:3Q6PPC19PO


subject: UNII:3Q6PPC19PO


subject: UNII:3Q6PPC19PO


subject: UNII:HOY74VZE0M

subject_name: gadoxetate


subject: UNII:HOY74VZE0M


subject: UNII:HOY74VZE0M


subject: UNII:HOY74VZE0M


subject: UNII:HOY74VZE0M


subject: CHEBI:38721

subject_name: Methamidophos


subject: CHEBI:38721

object_name: viral disease


subject: UMLS:C1312686

subject_name: Femarelle


subject: CHEBI:50692

subject_name: Mifepristone

object_name: Hypercortisolism, mild


subject: GTOPDB:7684

subject_name: lebrikizumab

object_name: asthma


subject: CHEMBL.COMPOUND:CHEMBL1743035

subject_name: LEBRIKIZUMAB


subject: UMLS:C1881890


subject: CHEBI:6402

subject_name: Leflunomide

object_name: chronic graft versus host disease


subject: CHEBI:6402

object_name: Steroid Refractory Graft Versus Host Disease


subject: UNII:RJ1IW3B4QX

subject_name: Tezepelumab

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix


subject: UMLS:C0971731


subject: CHEBI:95021

subject_name: pemetrexed

object_name: cancer


subject: CHEBI:63724


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: acne


subject: MESH:D010919

subject_name: Placebos

object_name: adult lymphoma


subject: MESH:D010919

object_name: lymphoma


subject: MESH:D010919

object_name: pediatric lymphoma


subject: MESH:D010919

object_name: plasma cell myeloma


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: thrombocytopenia due to immune destruction


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C1614968

subject_name: Sativex

object_name: head and neck squamous cell carcinoma


subject: UMLS:C1739735

subject_name: Mycograb

object_name: breast carcinoma


subject: UMLS:C1739735

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL2108758

subject_name: PEPPERMINT OIL

object_name: hypertension


subject: CHEMBL.COMPOUND:CHEMBL2108758

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:173480

object_name: major depressive disorder


subject: UMLS:C0244033


subject: UMLS:C3896652


subject: CHEMBL.COMPOUND:CHEMBL2109562

subject_name: CAL

object_name: Childhood Breast Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109562


subject: CHEMBL.COMPOUND:CHEMBL2109562


subject: CHEMBL.COMPOUND:CHEMBL2109562

object_name: Embolism, Tumor


subject: CHEMBL.COMPOUND:CHEMBL2109562

object_name: Neoplasm Metastasis


subject: CHEMBL.COMPOUND:CHEMBL2109562

object_name: Metastasis


subject: CHEMBL.COMPOUND:CHEMBL2109562

object_name: Metastatic Lesion


subject: CHEMBL.COMPOUND:CHEMBL2109562

object_name: breast neoplasm


subject: PR:000008147

subject_name: Golgi-associated PDZ and coiled-coil motif-containing protein


subject: PR:000008147


subject: PR:000008147


subject: PR:000008147


subject: PR:000008147


subject: PR:000008147


subject: PR:000008147


subject: PR:000008147


subject: UMLS:C1135160

subject_name: monoclonal antibody CAL


subject: UMLS:C1135160


subject: UMLS:C1135160


subject: UMLS:C1135160


subject: UMLS:C1135160


subject: UMLS:C1135160


subject: UMLS:C1135160


subject: UMLS:C1135160


subject: PR:000007357

subject_name: filamin-binding LIM protein 1


subject: PR:000007357


subject: PR:000007357


subject: PR:000007357


subject: PR:000007357


subject: PR:000007357


subject: PR:000007357


subject: PR:000007357


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: Carnitine deficiency due to hemodialysis


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: Metastatic well-differentiated neuroendocrine tumor


subject: CHEBI:231347

subject_name: Triapine

object_name: Metastatic Digestive System Neuroendocrine Neoplasm


subject: CHEBI:27470

subject_name: Folic acid

object_name: eating disorder


subject: CHEBI:17933

subject_name: Calcifediol

object_name: pulmonary hypertension


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Graft Rejection


subject: CHEBI:9168

object_name: kidney failure


subject: CHEMBL.COMPOUND:CHEMBL4297970

subject_name: MELRILIMAB

object_name: asthma


subject: UMLS:C5421171

subject_name: melrilimab


subject: UMLS:C5828933


subject: CHEBI:73611

subject_name: Met-Gly


subject: PR:000004501

subject_name: attractin


subject: UMLS:C0487173

subject_name: Mg antigen


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Diamond-Blackfan anemia


subject: CHEBI:4026

object_name: Aase syndrome


subject: CHEBI:4026

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:4026

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:4026

object_name: congenital amegakaryocytic thrombocytopenia 1


subject: CHEBI:4026


subject: CHEBI:4026

object_name: Chronic leukemia in remission


subject: CHEBI:4026

object_name: chronic granulomatous disease


subject: CHEBI:4026

object_name: hyper-IgM syndrome type 1


subject: CHEBI:4026

object_name: Shwachman-Diamond syndrome


subject: CHEBI:4026

object_name: Shwachman-Diamond syndrome 1


subject: CHEBI:4026

object_name: Thrombasthenia


subject: CHEBI:4026

object_name: constitutional neutropenia


subject: CHEBI:4026

object_name: severe congenital neutropenia


subject: CHEBI:4026

object_name: Wiskott-Aldrich syndrome


subject: CHEBI:4026

object_name: acquired polycythemia vera


subject: CHEBI:4026

object_name: thalassemia


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: sickle cell disease


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368

object_name: immunodeficiency disease


subject: PUBCHEM.COMPOUND:3368

object_name: inborn error of immunity


subject: PUBCHEM.COMPOUND:3368

object_name: T-Cell Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: B-cell non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: B-cell neoplasm


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine

object_name: Chronic leukemia in remission


subject: CHEBI:63599

object_name: chronic granulomatous disease


subject: CHEBI:63599

object_name: hyper-IgM syndrome type 1


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: UNII:81U49K9009

object_name: cystic fibrosis


subject: CHEBI:74073

subject_name: Ile-Met

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:30366

subject_name: imidazolide


subject: MESH:D000077325

subject_name: Ringer's Lactate

object_name: acute pancreatitis


subject: CHEBI:681850

subject_name: Conivaptan

object_name: intracerebral hemorrhage


subject: CHEBI:681850

object_name: brain edema


subject: CHEBI:681850

object_name: stroke disorder


subject: CHEBI:681850

object_name: cerebrovascular disorder


subject: CHEBI:681850

object_name: Stroke (heart beat)


subject: CHEBI:681850

object_name: Stroke, CTCAE


subject: UMLS:C5761796

subject_name: GVAX

object_name: Myelodysplasia


subject: UMLS:C5761796

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C5761796

object_name: childhood myelodysplastic syndrome


subject: UMLS:C5761796

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C5761796

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C5761796

object_name: chronic myelomonocytic leukemia


subject: UMLS:C5761796

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5761796

object_name: acute myeloid leukemia


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: post operative nausea and vomiting


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:MK7HP94ZUP

object_name: influenza


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Early Stage Breast Carcinoma


subject: CHEBI:6129

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: UNII:N0GBZ1GWC2

subject_name: TRONTINEMAB

object_name: Alzheimer disease


subject: UMLS:C5707904

subject_name: Trontinemab


subject: CHEBI:95089

subject_name: Ipatasertib

object_name: triple-negative breast carcinoma


subject: CHEBI:95089

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: stroke disorder


subject: PUBCHEM.COMPOUND:11227182

subject_name: Lipitor

object_name: inherited lipid metabolism disorder


subject: PUBCHEM.COMPOUND:11227182

object_name: Dyslipidemia


subject: PUBCHEM.COMPOUND:11227182

object_name: peripheral vascular disease


subject: PUBCHEM.COMPOUND:11227182

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:11227182

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:11227182

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:11227182


subject: PUBCHEM.COMPOUND:11227182

object_name: cerebrovascular disorder


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:56841998

subject_name: Epoch

object_name: Hodgkin Disease


subject: PUBCHEM.COMPOUND:56841998

object_name: Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:56841998

object_name: Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:56841998

object_name: diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:56841998

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:56841998

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEBI:63626

subject_name: Tesamorelin

object_name: HIV infection


subject: UMLS:C1313807


subject: CHEBI:45716

subject_name: Vorinostat

object_name: skin neoplasm


subject: PUBCHEM.COMPOUND:46200932

subject_name: Balovaptan

object_name: post-traumatic stress disorder


subject: UNII:RAX5D5AGV6


subject: MESH:C528512

subject_name: FluBlok

object_name: influenza


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: Advanced renal cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743016

subject_name: FARLETUZUMAB

object_name: malignant epithelial tumor of ovary


subject: UMLS:C1831845


subject: UNII:EL55307L15

subject_name: ANCROD

object_name: stroke disorder


subject: UNII:EL55307L15


subject: UNII:EL55307L15

object_name: Stroke (heart beat)


subject: UNII:EL55307L15

object_name: Stroke, CTCAE


subject: UNII:EL55307L15

object_name: brain ischemia


subject: UNII:EL55307L15

object_name: cerebral infarction


subject: UNII:EL55307L15

object_name: brain infarction


subject: UMLS:C0002823

subject_name: ancrod


subject: UMLS:C0002823

object_name: cerebrovascular disorder


subject: UMLS:C0002823


subject: UMLS:C0002823


subject: UMLS:C0002823


subject: UMLS:C0002823


subject: UMLS:C0002823


subject: CHEBI:63638

subject_name: Vigabatrin

object_name: complex partial epilepsy


subject: GTOPDB:8357

subject_name: donanemab

object_name: nervous system disorder


subject: GTOPDB:8357

object_name: neurodegenerative disease


subject: GTOPDB:8357

object_name: cognitive disorder


subject: GTOPDB:8357

object_name: mental disorder


subject: GTOPDB:8357

object_name: psychiatric disorder


subject: GTOPDB:8357

object_name: tauopathy


subject: UNII:1ADB65P1KK

subject_name: DONANEMAB


subject: UNII:1ADB65P1KK


subject: UNII:1ADB65P1KK


subject: UNII:1ADB65P1KK


subject: UNII:1ADB65P1KK


subject: UNII:1ADB65P1KK


subject: UMLS:C5237999


subject: UMLS:C5237999


subject: UMLS:C5237999


subject: UMLS:C5237999


subject: UMLS:C5237999


subject: UMLS:C5237999


subject: UMLS:C2348261

subject_name: Dietary Chromium

object_name: glucose intolerance


subject: UMLS:C2348261

object_name: Impaired glucose tolerance


subject: UMLS:C2348261

object_name: Insulin resistance


subject: UMLS:C2348261

object_name: Impaired fasting glucose


subject: UMLS:C2348261

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C2348261

object_name: obesity


subject: UMLS:C2348261

object_name: Obesity, CTCAE


subject: CHEBI:28073

subject_name: Chromium


subject: CHEBI:28073


subject: CHEBI:28073


subject: CHEBI:28073


subject: CHEBI:28073


subject: CHEBI:28073


subject: CHEBI:28073


subject: CHEBI:49544

subject_name: Chromic cation


subject: CHEBI:49544


subject: CHEBI:49544


subject: CHEBI:49544


subject: CHEBI:49544


subject: CHEBI:49544


subject: CHEBI:49544


subject: CHEBI:94807

subject_name: Nitazoxanide

object_name: chronic hepatitis B virus infection


subject: CHEBI:94807

object_name: hepatitis B


subject: CHEBI:174428

object_name: heart disorder


subject: CHEBI:15414

subject_name: Adomet


subject: CHEBI:67040

subject_name: Ademetionine


subject: UMLS:C5417952

subject_name: SHP2 Inhibitor RLY-1971

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:49849451

subject_name: Anacetrapib


subject: PUBCHEM.COMPOUND:49849451

object_name: familial hypercholesterolemia


subject: CHEBI:46345

subject_name: Fluorouracil

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: CHEBI:46345

object_name: vitiligo


subject: CHEBI:63925

subject_name: PhXa 85


subject: CHEBI:63925


subject: CHEBI:94366

subject_name: itraconazole

object_name: breast neoplasm


subject: CHEBI:94366

object_name: Neoplasm Metastasis


subject: CHEBI:73688

subject_name: Ac-Asp-Glu

object_name: atopic conjunctivitis


subject: UMLS:C0771562

subject_name: isospaglumic acid


subject: CHEBI:191259


subject: UMLS:C0130693

subject_name: N-acetyl-aspartyl-glutamate


subject: MESH:D000077325

subject_name: Ringer's Lactate

object_name: Metabolic ketoacidosis


subject: MESH:D000077325

object_name: maple syrup urine disease


subject: MESH:D000077325

object_name: Ketosis


subject: MESH:D000077325

object_name: Acetonemia


subject: MESH:D000077325

object_name: Ketonuria


subject: PUBCHEM.COMPOUND:333445

subject_name: RL


subject: PUBCHEM.COMPOUND:333445


subject: PUBCHEM.COMPOUND:333445


subject: PUBCHEM.COMPOUND:333445


subject: PUBCHEM.COMPOUND:333445


subject: CHEBI:73815

subject_name: Arg-Leu


subject: CHEBI:73815


subject: CHEBI:73815


subject: CHEBI:73815


subject: CHEBI:73815


subject: UMLS:C0445115

subject_name: Normal saline


subject: UMLS:C0445115


subject: UMLS:C0445115


subject: UMLS:C0445115


subject: UMLS:C0445115


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: CHEBI:26710


subject: CHEBI:26710


subject: CHEBI:26710


subject: CHEBI:33330

subject_name: scandium atom


subject: CHEBI:33330


subject: CHEBI:33330


subject: CHEBI:33330


subject: CHEBI:33330


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000007182


subject: PR:000007182


subject: PR:000007182


subject: PR:000007182


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: PR:000050188


subject: PR:000050188


subject: PR:000050188


subject: PR:000050188


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Metrorrhagia


subject: CHEBI:94518

object_name: Break-through bleeding (finding)


subject: CHEBI:49662

subject_name: Indomethacin

object_name: Extreme immaturity


subject: CHEBI:49662

object_name: Intraventricular hemorrhage


subject: CHEBI:49662

object_name: newborn morbidity


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: type 2 diabetes mellitus


subject: UMLS:C3714803

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C3714803

object_name: obesity


subject: UMLS:C3714803

object_name: Obesity, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:5494

subject_name: ritropirronium bromide

object_name: Postoperative Residual Curarization


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: non-small cell lung carcinoma


subject: CHEBI:151315

subject_name: Heparin

object_name: Renal cell carcinoma recurrent


subject: CHEBI:151315

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:151315

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:151315

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:151315

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:151315

object_name: Stage III renal cell cancer


subject: CHEBI:151315

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:151315

object_name: clear cell sarcoma of kidney


subject: GTOPDB:6803

subject_name: dalteparin


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:38940


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: adult lymphoma


subject: CHEBI:135918

object_name: lymphoma


subject: CHEBI:135918

object_name: pediatric lymphoma


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Drug-induced sleep disorder


subject: CHEBI:4466

object_name: sleep apnea


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: UMLS:C5561448

subject_name: efgartigimod alfa-fcab

object_name: Guillain-Barre syndrome


subject: UMLS:C5561448

object_name: Guillain-Barre Syndrome, CTCAE


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Klatskin Tumor


subject: GTOPDB:12990

subject_name: sintilimab


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: UNII:5W6YA9PKKH

subject_name: INDINAVIR

object_name: HIV infection


subject: CHEBI:82941

subject_name: Fosamprenavir


subject: CHEBI:174615

object_name: chronic granulomatous disease


subject: CHEBI:28901

subject_name: Busulfan


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:41423

subject_name: Celecoxib

object_name: bipolar disorder


subject: CHEBI:41423

object_name: bipolar depression


subject: CHEMBL.COMPOUND:CHEMBL2109602

object_name: neoplasm


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: schizophreniform disorder


subject: UMLS:C0358855

object_name: schizoaffective disorder


subject: UMLS:C0358855

object_name: schizophrenia 18


subject: UMLS:C0358855

object_name: Nonorganic psychosis


subject: UMLS:C0358855

object_name: Psychosis, CTCAE


subject: PUBCHEM.COMPOUND:92002593

subject_name: Ibritumomab

object_name: non-Hodgkin lymphoma


subject: UNII:4Q52C550XK

subject_name: Ibritumomab tiuxetan


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: colorectal cancer


subject: GTOPDB:7988

object_name: colorectal carcinoma


subject: GTOPDB:7988

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: CHEBI:59527

object_name: Chronic low back pain


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:77260

subject_name: Omeprazole


subject: UNII:5IB2J79MCX

subject_name: Spesolimab

object_name: ulcerative colitis


subject: CHEBI:17364

subject_name: D-Aspartic Acid

object_name: brain injury


subject: CHEBI:29990


subject: CHEBI:29994


subject: UMLS:C0949756

subject_name: D-Aspartate


subject: UMLS:C5565911

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:4911

subject_name: Etoposide

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:4911

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:4911

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:4911

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:4911

object_name: adult acute monocytic leukemia


subject: CHEBI:4911

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:4911

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:4911

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:4911

object_name: Adult Erythroleukemia


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:63791

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:63791

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:63791

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:63791

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:63791

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: UMLS:C0056562

subject_name: crystalloid solutions

object_name: Postoperative Complications


subject: CHEBI:192805

subject_name: Varespladib methyl

object_name: kidney failure


subject: CHEBI:7465

subject_name: Naltrexone

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:7465

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:7465

object_name: morbid obesity


subject: CHEBI:7465

object_name: Drug-induced obesity


subject: CHEBI:3219

subject_name: Bupropion


subject: CHEBI:3219


subject: CHEBI:3219


subject: CHEBI:3219


subject: CHEBI:135572

subject_name: Prednylidene

object_name: Hodgkin Disease


subject: CHEBI:135572

object_name: Adult Classical Hodgkin Lymphoma


subject: UMLS:C0021027

subject_name: Immunoglobulins

object_name: HIV infection


subject: UMLS:C0021027

object_name: Vertical Disease Transmission


subject: UMLS:C0021027

object_name: AIDS


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: dental caries


subject: PUBCHEM.COMPOUND:5281767

object_name: Dental Caries, CTCAE


subject: PUBCHEM.COMPOUND:9811567

subject_name: Advair

object_name: asthma


subject: UNII:QMS40680K6

subject_name: Palifermin

object_name: graft versus host disease


subject: CHEBI:84491

object_name: liver carcinoma


subject: UNII:O84C90HH2L

subject_name: Poly I-C


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Sepsis


subject: CHEBI:4466

object_name: Sepsis, CTCAE


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: osteonecrosis


subject: UNII:6XC1PAD3KF

object_name: avascular necrosis


subject: UNII:6XC1PAD3KF

object_name: Osteonecrosis, CTCAE


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:46557


subject: DRUGBANK:DB16738

subject_name: Ciltacabtagene autoleucel

object_name: smoldering plasma cell myeloma


subject: DRUGBANK:DB16738

object_name: plasma cell myeloma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: CHEBI:63599

subject_name: Fludarabine


subject: UNII:LPU25F15UQ

subject_name: Azeliragon

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: Upper Respiratory Infections


subject: UMLS:C0939788

subject_name: Zometa


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: BCLC Stage C Hepatocellular Carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Hepatocellular Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IVB Hepatocellular Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IVA Hepatocellular Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IIIB Hepatocellular Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IIIC Hepatocellular Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IIIA Hepatocellular Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Adult Hepatocellular Carcinoma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:3095

subject_name: Biguanide

object_name: type 2 diabetes mellitus


subject: MESH:D001645

subject_name: Biguanides


subject: UMLS:C3540012

subject_name: biguanide blood glucose lower drugs


subject: UMLS:C0360396

subject_name: Biguanide antimalarial


subject: UNII:01KC87F8FE


subject: PR:000010011

subject_name: lysosomal-trafficking regulator


subject: PR:000003655


subject: UMLS:C3537178

subject_name: Glinides


subject: UMLS:C3653359

subject_name: Sulfonylureas for blood glucose lowering


subject: CHEBI:50992


subject: UMLS:C3537039

subject_name: Thiazolidinedione [EPC]


subject: UMLS:C2267008

subject_name: alpha-Glucosidase Inhibitor [EPC]


subject: UMLS:C0212009

subject_name: I-antigen


subject: UNII:953A26OA1Y

subject_name: Dornase alfa

object_name: familial acute respiratory distress syndrome, ANLN-related, dog


subject: UNII:953A26OA1Y

object_name: acute respiratory distress syndrome


subject: UNII:953A26OA1Y

object_name: COVID-19-Associated Acute Respiratory Distress Syndrome


subject: UNII:953A26OA1Y

object_name: adult acute respiratory distress syndrome


subject: DRUGBANK:DB05942

object_name: hepatitis C


subject: UMLS:C0540212

object_name: hyperphosphatemia


subject: UMLS:C0540212

object_name: Serum phosphate concentrations above normal (finding)


subject: UMLS:C0540212

object_name: Hyperphosphatemia, CTCAE


subject: UMLS:C0540212

object_name: chronic kidney disease


subject: UMLS:C0540212

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:16991

subject_name: DNA

object_name: HIV infection


subject: UMLS:C0678021

subject_name: Ad5CMV-p53 gene

object_name: lip and oral cavity carcinoma


subject: UMLS:C0678021

object_name: Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7


subject: UMLS:C0678021

object_name: oropharyngeal carcinoma


subject: UMLS:C0678021

object_name: oropharynx cancer


subject: UMLS:C0678021

object_name: tongue cancer


subject: UMLS:C0678021

object_name: tongue carcinoma


subject: UMLS:C0678021

object_name: carcinoma in situ of oropharynx


subject: UMLS:C5205615

subject_name: Lipid Nanoparticle Encapsulated mRNAs Encoding Human IL-12A/IL-12B MEDI-1191

object_name: Solid Neoplasm


subject: UMLS:C5205615

object_name: cancer


subject: UMLS:C5205615

object_name: neoplasm


subject: CHEBI:4875

subject_name: Etanercept

object_name: Acne inversa


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: CHEMBL.COMPOUND:CHEMBL2134724

subject_name: IPRATROPIUM BROMIDE

object_name: Parkinson disease


subject: CHEBI:5957

subject_name: ipratropium bromide hydrate


subject: PUBCHEM.COMPOUND:3021749


subject: UNII:J697UZ2A9J


subject: PUBCHEM.COMPOUND:657309

subject_name: Ipratropium


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UNII:QQA9MLH692

subject_name: Tafasitamab

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C2987409


subject: CHEBI:53013

object_name: Post-Operative Pain


subject: CHEBI:17361

subject_name: CMP


subject: CHEBI:60377

subject_name: cytidine 5'-monophosphate(2-)


subject: PR:000010205

subject_name: cartilage matrix protein


subject: CHEBI:22587

subject_name: antiviral agent

object_name: Zygomycosis


subject: UMLS:C0003451

subject_name: Antiviral Agents


subject: UMLS:C5551438

subject_name: Antiviral [EPC]


subject: UNII:7NL2E3F6K3

subject_name: Emicizumab

object_name: Hereditary factor VIII deficiency disease without inhibitor


subject: CHEBI:151315

subject_name: Heparin

object_name: Venous thrombosis after immobility


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN

object_name: thrombophilia due to thrombin defect


subject: UNII:E47C0NF7LV


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: HMDB:HMDB0256702

subject_name: Porfimer Sodium

object_name: Neck Carcinoma


subject: HMDB:HMDB0256702

object_name: head and neck neoplasm


subject: HMDB:HMDB0256702

object_name: head and neck cancer


subject: UNII:Y3834SIK5F

subject_name: PORFIMER SODIUM


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: CHEBI:50730

subject_name: Montelukast

object_name: Premature Labor


subject: CHEBI:25017

subject_name: leucine

object_name: Depressed mood


subject: CHEBI:25017

object_name: Cancer patients and suicide and depression


subject: CHEBI:25017

object_name: Depressed - symptom


subject: CHEBI:25017

object_name: Depression, CTCAE


subject: HMDB:HMDB0013470

subject_name: LPS with O-antigen


subject: HMDB:HMDB0013470


subject: HMDB:HMDB0013470


subject: HMDB:HMDB0013470


subject: CHEBI:16412

subject_name: Lysophosphotidylserine


subject: CHEBI:16412


subject: CHEBI:16412


subject: CHEBI:16412


subject: PUBCHEM.COMPOUND:155977629


subject: PUBCHEM.COMPOUND:155977629


subject: PUBCHEM.COMPOUND:155977629


subject: PUBCHEM.COMPOUND:155977629


subject: CHEBI:89981

subject_name: Endotoxins


subject: CHEBI:89981


subject: CHEBI:89981


subject: CHEBI:89981


subject: CHEBI:52603


subject: CHEBI:52603


subject: CHEBI:52603


subject: CHEBI:52603


subject: GTOPDB:5019

subject_name: LPS


subject: GTOPDB:5019


subject: GTOPDB:5019


subject: GTOPDB:5019


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: PR:000001155

subject_name: Toll-like receptor 4


subject: PR:000001155


subject: PR:000001155


subject: PR:000001155


subject: UMLS:C1614968

subject_name: Sativex

object_name: peripheral nervous system disorder


subject: UMLS:C1614968

object_name: neuropathy


subject: UMLS:C2346492

subject_name: Indocyanine Green Solution

object_name: Endometrial High Grade Endometrioid Adenocarcinoma


subject: UMLS:C2346492

object_name: endometrial clear cell adenocarcinoma


subject: UMLS:C2346492

object_name: endometrial serous adenocarcinoma


subject: UMLS:C2346492

object_name: endometrial mixed adenocarcinoma


subject: UMLS:C2346492

object_name: carcinosarcoma


subject: UMLS:C3896888

subject_name: CCR2 Antagonist CCX872-B

object_name: pancreatic adenocarcinoma


subject: UMLS:C3896888

object_name: pancreatic neoplasm


subject: UMLS:C3896888

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3896888

object_name: malignant pancreatic neoplasm


subject: UMLS:C0032375

subject_name: Oral Poliovirus Vaccine

object_name: gastroenteritis


subject: UMLS:C0032375

object_name: Rotavirus infection


subject: UMLS:C0597418

subject_name: Rotavirus Vaccines


subject: UMLS:C0597418


subject: UMLS:C5397359

subject_name: Vaccine product containing only Rotavirus antigen (medicinal product)


subject: UMLS:C5397359


subject: CHEBI:6801

subject_name: Metformin

object_name: obstructive sleep apnea syndrome


subject: CHEBI:53758

subject_name: PAP


subject: CHEBI:17985

subject_name: Adenosine 3',5'-diphosphate


subject: CHEBI:10127

subject_name: Zonisamide

object_name: Parkinson disease


subject: UMLS:C4310511

subject_name: Mysimba

object_name: Liver Fibrosis


subject: UMLS:C4310511

object_name: Fatty Liver


subject: UMLS:C4310511

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C4310511

object_name: Overweight or obesity


subject: UMLS:C4310511

object_name: type 2 diabetes mellitus


subject: UMLS:C4310511

object_name: inherited lipid metabolism disorder


subject: UMLS:C4310511

object_name: Dyslipidemia


subject: UMLS:C4310511

object_name: hypertension


subject: UMLS:C4310511

object_name: Hypertension, CTCAE


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: anemia


subject: CHEBI:91397

object_name: Anemia, CTCAE


subject: PUBCHEM.COMPOUND:132279048

subject_name: Iron hydroxide adipate

object_name: chronic kidney disease


subject: CHEBI:7852

subject_name: Oxycodone

object_name: Narcotic Abuse


subject: CHEBI:7852

object_name: chronic pain (diagnosis)


subject: CHEBI:7852

object_name: Chronic pain


subject: CHEBI:7852

object_name: Acute Pain


subject: CHEBI:7852

object_name: pain agnosia


subject: CHEBI:7852

object_name: Pain insensitivity


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: acute liver failure


subject: CHEBI:28939

object_name: hepatic encephalopathy


subject: CHEBI:474053

subject_name: Cefazolin

object_name: periprosthetic joint infection


subject: CHEBI:600103

subject_name: daptomycin


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:174615

object_name: Myelofibrosis due to another disorder


subject: CHEBI:174615

object_name: IDH2 gene mutation


subject: CHEBI:174615

object_name: IDH1 gene mutation


subject: CHEBI:174615

object_name: EZH2 gene mutation


subject: CHEBI:174615

object_name: ASXL1 gene mutation


subject: CHEBI:174615

object_name: thrombocytopenia


subject: CHEBI:174615

object_name: anemia


subject: CHEBI:174615

object_name: Anemia, CTCAE


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:174615

object_name: Burkitt lymphoma


subject: CHEBI:174615

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:174615

object_name: Adult Burkitt Lymphoma


subject: CHEBI:174615

object_name: lymphoplasmacytic lymphoma


subject: CHEBI:174615

object_name: T-cell lymphoma recurrent


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:41264

subject_name: butyl group

object_name: Hodgkin Disease


subject: CHEBI:41264

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:41264

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:41264

object_name: mantle cell lymphoma


subject: CHEBI:41264


subject: CHEBI:41264


subject: CHEBI:41264


subject: CHEBI:41264


subject: CHEBI:41264

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:41264


subject: CHEBI:41264

object_name: acute lymphoblastic leukemia


subject: CHEBI:41264

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:41264

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:41264

object_name: acute myeloid leukemia


subject: CHEBI:41264

object_name: Myelodysplasia


subject: CHEBI:41264

object_name: Myelodysplasia, CTCAE


subject: CHEBI:4026


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599


subject: PR:000022673

subject_name: antigen 43


subject: PR:000022673


subject: PR:000022673


subject: PR:000022673


subject: PR:000022673


subject: PR:000022673


subject: PR:000022673


subject: PR:000022673


subject: PR:000022673


subject: PR:000022673


subject: PR:000022673


subject: PR:000022673


subject: PR:000022673


subject: PR:000022673


subject: PR:000022673


subject: PR:000022673


subject: GTOPDB:4934

subject_name: G-CSF


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:53498

subject_name: triacetylcellulose


subject: CHEBI:53498


subject: CHEBI:53498


subject: CHEBI:53498


subject: CHEBI:53498


subject: CHEBI:53498


subject: CHEBI:53498


subject: CHEBI:53498


subject: CHEBI:53498


subject: CHEBI:53498


subject: CHEBI:53498


subject: CHEBI:53498


subject: CHEBI:53498


subject: CHEBI:53498


subject: CHEBI:53498


subject: CHEBI:53498


subject: UMLS:C2962221

subject_name: TAC


subject: UMLS:C2962221


subject: UMLS:C2962221


subject: UMLS:C2962221


subject: UMLS:C2962221


subject: UMLS:C2962221


subject: UMLS:C2962221


subject: UMLS:C2962221


subject: UMLS:C2962221


subject: UMLS:C2962221


subject: UMLS:C2962221


subject: UMLS:C2962221


subject: UMLS:C2962221


subject: UMLS:C2962221


subject: UMLS:C2962221


subject: UMLS:C2962221


subject: CHEBI:5551

subject_name: Guaifenesin

object_name: common cold


subject: GTOPDB:12652

subject_name: magrolimab

object_name: castration-resistant prostate carcinoma


subject: GTOPDB:12652

object_name: Stage IVB Prostate Cancer AJCC v8


subject: GTOPDB:12652

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: CHEBI:83766

subject_name: Olaparib


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: combined hepatocellular carcinoma and cholangiocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Liver Cancer


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Adult Liver Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIB Adult Liver Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIC Adult Liver Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Liver Cancer


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIA Adult Liver Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Adult Liver Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C1831831

subject_name: GI-4000 Vaccine

object_name: pancreatic neoplasm


subject: UMLS:C1831831

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1831831

object_name: malignant pancreatic neoplasm


subject: UMLS:C1548480

subject_name: hepatitis E vaccine

object_name: hepatitis A


subject: UMLS:C1548480

object_name: hepatitis


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: strabismus


subject: CHEBI:4466

object_name: strabismus on exam (physical finding)


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: plague


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Adult Classical Hodgkin Lymphoma


subject: UMLS:C2346820


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:52717

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:52717

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:52717

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:52717

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:52717

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:52717

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:52717

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:52717

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:52717

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: CHEBI:52717

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:52717

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:52717

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: CHEBI:52717

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:52717

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:52717

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: CHEBI:52717

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:52717

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:52717

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:52717

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: CHEBI:52717

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:52717

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:52717

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:52717

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:52717

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:52717

object_name: Laryngeal verrucous carcinoma stage IV


subject: CHEBI:52717

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: CHEBI:52717

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: CHEBI:52717

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: CHEBI:52717

object_name: tongue cancer


subject: CHEBI:52717

object_name: tongue carcinoma


subject: CHEBI:90881

subject_name: Camptosar

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:90881

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:90881

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:90881

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:90881

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:90881

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:90881

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:90881

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:90881

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:90881

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: CHEBI:90881

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:90881

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:90881

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: CHEBI:90881

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:90881

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:90881

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: CHEBI:90881

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:90881

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:90881

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:90881

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: CHEBI:90881

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:90881

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:90881

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:90881

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:90881

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:90881

object_name: Laryngeal verrucous carcinoma stage IV


subject: CHEBI:90881

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: CHEBI:90881

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: CHEBI:90881

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: CHEBI:90881

object_name: tongue cancer


subject: CHEBI:90881

object_name: tongue carcinoma


subject: CHEBI:8988

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:8988

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:8988

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:8988

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:8988

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:8988

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:8988

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:8988

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:8988

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:8988

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: CHEBI:8988

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:8988

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:8988

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: CHEBI:8988

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:8988

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:8988

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: CHEBI:8988

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:8988

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:8988

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:8988

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: CHEBI:8988

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:8988

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:8988

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:8988

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:8988

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:8988

object_name: Laryngeal verrucous carcinoma stage IV


subject: CHEBI:8988

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: CHEBI:8988

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: CHEBI:8988

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: CHEBI:8988

object_name: tongue cancer


subject: CHEBI:8988

object_name: tongue carcinoma


subject: CHEBI:80630

subject_name: Irinotecan

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:80630

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:80630

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:80630

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:80630

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:80630

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:80630

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:80630

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:80630

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:80630

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: CHEBI:80630

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:80630

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:80630

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: CHEBI:80630

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:80630

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:80630

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: CHEBI:80630

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:80630

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:80630

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:80630

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: CHEBI:80630

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:80630

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:80630

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:80630

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:80630

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:80630

object_name: Laryngeal verrucous carcinoma stage IV


subject: CHEBI:80630

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: CHEBI:80630

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: CHEBI:80630

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: CHEBI:80630

object_name: tongue cancer


subject: CHEBI:80630

object_name: tongue carcinoma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: obstructive sleep apnea syndrome


subject: UNII:T12B44A1OE

subject_name: Acoramidis

object_name: Transthyretin-related (ATTR) familial amyloid polyneuropathy


subject: UNII:V7FWP1D62O

subject_name: NERVE GROWTH FACTOR

object_name: Ischemic stroke


subject: CHEBI:8405

subject_name: Primaquine

object_name: Plasmodium falciparum malaria


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage IVB Lung Cancer AJCC v8


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Non-small cell lung cancer recurrent


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: mantle cell lymphoma


subject: UMLS:C1541395


subject: CHEBI:4469

subject_name: dexamfetamine

object_name: cocaine abuse


subject: CHEBI:4469

object_name: substance-related disorder


subject: UMLS:C1971782

subject_name: DEXTROAMPHETAMINE SULFATE, 5 MG ADMINISTERED


subject: UMLS:C1971782


subject: UMLS:C0907160

subject_name: Pegylated Interferon Alfa

object_name: chronic hepatitis B virus infection


subject: UMLS:C0907160

object_name: hepatitis B


subject: UMLS:C5666882

subject_name: SARS-CoV-2 Spike Protein DNA Vaccine VAX-001


subject: UMLS:C1134696

object_name: bladder tumor


subject: UMLS:C1134696

object_name: urinary bladder carcinoma


subject: UMLS:C1134696

object_name: urinary bladder cancer


subject: UMLS:C1134696

object_name: childhood bladder carcinoma


subject: UMLS:C2983727

subject_name: ensituximab

object_name: Pancreatic cancer, adult


subject: CHEBI:84040

object_name: type 1 diabetes mellitus 1


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: UMLS:C2001573

object_name: atrial fibrillation


subject: UMLS:C2001573

object_name: Atrial Fibrillation by ECG Finding


subject: UMLS:C2001573

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:90881

subject_name: Camptosar

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: CHEBI:90881

object_name: gallbladder cancer


subject: CHEBI:90881

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage III Gallbladder Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: CHEBI:90881

object_name: gallbladder carcinoma


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: UMLS:C5417812

subject_name: Finotonlimab

object_name: esophageal squamous cell carcinoma


subject: UMLS:C5417812

object_name: colorectal cancer


subject: UMLS:C5417812

object_name: colorectal carcinoma


subject: UMLS:C5417812

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3896769

subject_name: Anti-EGFR Monoclonal Antibody SCT200


subject: UMLS:C3896769


subject: UMLS:C3896769


subject: UMLS:C3896769


subject: CHEMBL.COMPOUND:CHEMBL2108465

subject_name: GINGER

object_name: puerperal disorder


subject: UNII:C5529G5JPQ

subject_name: ginger extract


subject: CHEBI:34574

object_name: kidney disorder


subject: CHEBI:42085

subject_name: 7,8-Diamino-Nonanoic Acid


subject: CHEBI:16026

subject_name: 2,6-Diaminopimelic Acid


subject: CHEBI:2247

subject_name: 7,8-diaminononanoic acid


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: HIV-1 infection


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:39867

subject_name: Valproic acid

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:39867

object_name: acute myeloid leukemia


subject: UMLS:C5201181

subject_name: H.P. acthar gel

object_name: Transplant glomerulopathy


subject: CHEBI:41423

subject_name: Celecoxib

object_name: malignant peritoneal mesothelioma


subject: CHEBI:41423

object_name: peritoneal carcinomatosis


subject: CHEBI:41423

object_name: malignant neoplasm of pancreas metastatic to peritoneal surface


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b


subject: UNII:43K1W2T1M6


subject: UNII:43K1W2T1M6


subject: UMLS:C0021735

subject_name: Viraferon


subject: UMLS:C0021735


subject: UMLS:C0021735


subject: UMLS:C5552625

subject_name: Interferon alfa-2b [EPC]


subject: UMLS:C5552625


subject: UMLS:C5552625


subject: PUBCHEM.COMPOUND:135537060

subject_name: Rintatolimod


subject: PUBCHEM.COMPOUND:135537060


subject: PUBCHEM.COMPOUND:135537060


subject: UNII:94325AJ25N

subject_name: RINTATOLIMOD


subject: UNII:94325AJ25N


subject: UNII:94325AJ25N


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Head and neck cancer metastatic


subject: UNII:DPT0O3T46P

object_name: Recurrent Malignant Head and Neck Neoplasm


subject: CHEBI:3752

subject_name: Clomifene

object_name: Cytochrome p450 CYP3A enzyme deficiency


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: anovulation


subject: CHEBI:3732

object_name: Female infertility associated with anovulation


subject: CHEBI:3732


subject: CHEBI:7936

subject_name: Paroxetine


subject: CHEBI:7936


subject: CHEBI:7936


subject: UNII:0K5743G68X

subject_name: Lemborexant

object_name: Drug Interactions


subject: UNII:0K5743G68X

object_name: Adverse drug interaction


subject: UNII:0K5743G68X

object_name: opiate dependence


subject: CHEBI:63631

subject_name: Topiramate

object_name: Gambling


subject: UMLS:C2355447

object_name: multiple sclerosis


subject: UMLS:C2355447

object_name: Parkinson disease


subject: UMLS:C2355447

object_name: Alzheimer disease type 1


subject: UMLS:C2355447

object_name: Alzheimer disease


subject: CHEBI:18132

subject_name: phosphocholine

object_name: hematologic disorder


subject: UniProtKB:Q62857

subject_name: DDIT3_RAT DNA damage-inducible transcript 3 protein (sprot)


subject: PR:000006347

subject_name: DNA damage-inducible transcript 3 protein


subject: CHEBI:28445

subject_name: vincristine


subject: UNII:D2A6T4UH9C

subject_name: Centanafadine

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:49005

subject_name: Deferasirox

object_name: Iron Overload


subject: CHEBI:49005

object_name: iron poisoning


subject: CHEBI:49005

object_name: Iron Overload, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL4650401

object_name: arterial calcification of infancy


subject: CHEMBL.COMPOUND:CHEMBL4650401

object_name: autosomal recessive hypophosphatemic rickets


subject: CHEMBL.COMPOUND:CHEMBL4650401

object_name: pseudoxanthoma elasticum (inherited or acquired)


subject: CHEMBL.COMPOUND:CHEMBL4650401

object_name: elastoma


subject: CHEMBL.COMPOUND:CHEMBL4650401

object_name: autosomal recessive inherited pseudoxanthoma elasticum


subject: UMLS:C5814286


subject: UMLS:C5814286


subject: UMLS:C5814286


subject: UMLS:C5814286


subject: UMLS:C5814286


subject: CHEBI:3921

subject_name: Cromakalim

object_name: Aura


subject: CHEBI:3921

object_name: migraine


subject: CHEBI:6436

subject_name: Levcromakalim


subject: CHEBI:6436


subject: UMLS:C0244960


subject: UMLS:C0244960


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: glycogen storage disease II


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: Ewing's sarcoma recurrent


subject: PUBCHEM.COMPOUND:49865963

object_name: Recurrent Childhood Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:49865963

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:49865963

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:49865963

object_name: Ewing sarcoma


subject: PUBCHEM.COMPOUND:49865963

object_name: peripheral primitive neuroectodermal tumor


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: CHEBI:82975

subject_name: Naloxegol

object_name: brain injury


subject: CHEBI:28911

subject_name: cob(III)alamin

object_name: Disorder of vitamin B12


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: CHEBI:176843

subject_name: vitamin B12


subject: UMLS:C0086024

subject_name: cobalamins


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: persistent fetal circulation syndrome


subject: CHEBI:192614

object_name: alveolar capillary dysplasia with misalignment of pulmonary veins


subject: CHEBI:192614

object_name: Persistent Pulmonary Hypertension of the Newborn, AE


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:9139


subject: CHEBI:90881

subject_name: Camptosar

object_name: malignant soft tissue neoplasm


subject: CHEBI:90881

object_name: sarcoma


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: Acute Stroke


subject: CHEBI:8093

object_name: Progressing stroke


subject: CHEBI:6801

subject_name: Metformin

object_name: acute coronary syndrome


subject: CHEBI:95165

object_name: acute lymphoblastic leukemia


subject: CHEBI:95165

object_name: Pre T-ALL


subject: CHEBI:95165

object_name: precursor B-cell acute lymphoblastic leukemia


subject: CHEBI:95165

object_name: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma


subject: CHEBI:95165

object_name: B-cell acute lymphoblastic leukemia


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: UNII:7D96IR0PPM


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:45716

subject_name: Vorinostat


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:84040

object_name: mild neurocognitive disorder


subject: CHEBI:84040

object_name: mild cognitive impairment


subject: CHEBI:84040

object_name: Mental deterioration


subject: CHEBI:84040

object_name: Cognitive impairment


subject: CHEBI:84040

object_name: Alzheimer disease type 1


subject: CHEBI:84040

object_name: Alzheimer disease


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:36002


subject: CHEBI:36002


subject: CHEBI:36002


subject: CHEBI:36002


subject: CHEBI:36002


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:27881


subject: CHEBI:27881


subject: CHEBI:27881


subject: CHEBI:27881


subject: CHEBI:27881


subject: CHEBI:57694


subject: CHEBI:57694


subject: CHEBI:57694


subject: CHEBI:57694


subject: CHEBI:57694


subject: CHEBI:57694


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:16243


subject: CHEBI:16243


subject: CHEBI:16243


subject: CHEBI:16243


subject: CHEBI:16243


subject: UMLS:C2935737

object_name: Childhood Breast Carcinoma


subject: UMLS:C2935737

object_name: breast carcinoma


subject: UMLS:C2935737

object_name: breast cancer


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: Allergy


subject: UMLS:C4086713

object_name: hypersensitivity reaction disease


subject: UMLS:C4086713

object_name: Antimicrobial susceptibility


subject: UMLS:C4086713

object_name: triple-negative breast carcinoma


subject: UMLS:C4086713

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: delirium


subject: CHEBI:46195

object_name: Delirium, CTCAE


subject: CHEBI:46195

object_name: lung neoplasm


subject: CHEBI:46195

object_name: age


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: choroidal neovascularization


subject: UNII:15C2VL427D

object_name: choroidal neovascularization (physical finding)


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22

object_name: biliary tract cancer


subject: PR:000014196

object_name: gallbladder cancer


subject: PR:000014196

object_name: bile duct carcinoma


subject: PR:000014196

object_name: cholangiocarcinoma


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: PR:000001919


subject: PR:000001919


subject: PR:000001919


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: heart failure


subject: CHEBI:16480

object_name: congestive heart failure


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: Nasal congestion


subject: CHEBI:6375

object_name: rhinitis


subject: CHEBI:90943

subject_name: Osimertinib

object_name: Non-small cell lung cancer stage II


subject: CHEBI:90943

object_name: Stage IIA Non-Small Cell Lung Carcinoma AJCC v7


subject: CHEBI:90943

object_name: stage IIA non-small cell lung cancer


subject: CHEBI:90943

object_name: Stage IIB Non-Small Cell Lung Carcinoma AJCC v7


subject: CHEBI:90943

object_name: stage IIB non-small cell lung cancer


subject: CHEBI:90943

object_name: Stage IB Non-Small Cell Lung Carcinoma AJCC v7


subject: CHEBI:90943

object_name: stage IB non-small cell lung cancer


subject: CHEBI:90943

object_name: Stage IA Lung Non-Small Cell Carcinoma AJCC v7


subject: UNII:R30772KCU0

subject_name: Isatuximab

object_name: Plasma cell myeloma refractory


subject: UNII:R30772KCU0

object_name: Plasma cell myeloma recurrent


subject: UMLS:C2983777


subject: UMLS:C2983777


subject: CHEBI:95165

object_name: diffuse large B-cell lymphoma


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:63660

object_name: HIV infection


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:33283

subject_name: THIAMINE

object_name: respiratory failure


subject: CHEBI:33283

object_name: acute respiratory failure


subject: UMLS:C3714802

subject_name: Thiamine Drug Class


subject: UMLS:C3714802


subject: CHEBI:18385

subject_name: Thiamine


subject: CHEBI:18385


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Adenocarcinoma of lung, stage I


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021

object_name: Neoplasms by Histologic Type


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: Childhood Solid Neoplasm


subject: CHEBI:68646

object_name: Adult Solid Neoplasm


subject: CHEBI:68646

object_name: Solid Neoplasm


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:192614

subject_name: Homosildenafil


subject: CHEBI:192614


subject: CHEBI:192614


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:9139


subject: UMLS:C3827474

subject_name: Wheatgrass Juice

object_name: Fatigue, CTCAE 5.0


subject: UMLS:C3827474

object_name: Fatigue


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:141969

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:141969

object_name: Chronic lymphocytic leukaemia stage 3


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: UMLS:C5447426

subject_name: HSV- thymidine Kinase-m2/hGM-CSF Genes-encoding GEN2

object_name: liver carcinoma


subject: UMLS:C5447426

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5447426

object_name: Embolism, Tumor


subject: UMLS:C5447426

object_name: Neoplasm Metastasis


subject: CHEBI:50249

subject_name: anticoagulant

object_name: MINOCA


subject: UMLS:C0003280

subject_name: Anticoagulants


subject: UMLS:C3536711

subject_name: Anti-coagulant [EPC]


subject: CHEBI:17632

subject_name: Nitrate


subject: UNII:MG7D3QD743

subject_name: Atiprimod

object_name: neuroendocrine carcinoma


subject: CHEBI:125628

subject_name: Alisertib

object_name: malignant epithelial tumor of ovary


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: lung carcinoid tumor


subject: UNII:2S9ZZM9Q9V

object_name: Advanced Adult Hepatocellular Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: ovarian carcinosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Pancreatic Neuroendocrine Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: carcinosarcoma of the corpus uteri


subject: UNII:2S9ZZM9Q9V

object_name: uterine carcinosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: ovarian serous surface papillary adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Regional Digestive System Neuroendocrine Tumor G1


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: UNII:2S9ZZM9Q9V

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: UNII:2S9ZZM9Q9V

object_name: PPoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Pancreatic Beta Cell Adenoma


subject: UNII:2S9ZZM9Q9V

object_name: Pancreatic Delta Cell Adenoma


subject: UNII:2S9ZZM9Q9V

object_name: Pancreatic Alpha Cell Adenoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Malignant Pancreatic Somatostatinoma


subject: UNII:2S9ZZM9Q9V

object_name: Pancreatic G-Cell Adenoma


subject: UNII:2S9ZZM9Q9V

object_name: Malignant gastrinoma of pancreas


subject: UNII:2S9ZZM9Q9V

object_name: Malignant Pancreatic Insulinoma


subject: UNII:2S9ZZM9Q9V

object_name: Glucagonoma, malignant


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: adult hepatocellular carcinoma


subject: CHEBI:79699

object_name: lung carcinoid tumor


subject: CHEBI:79699

object_name: Advanced Adult Hepatocellular Carcinoma


subject: CHEBI:79699

object_name: Recurrent Adult Liver Carcinoma


subject: CHEBI:79699

object_name: ovarian carcinosarcoma


subject: CHEBI:79699

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:79699

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:79699

object_name: Ovarian cancer stage IV


subject: CHEBI:79699

object_name: ovarian endometrioid adenocarcinoma


subject: CHEBI:79699

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:79699

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: CHEBI:79699

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:79699

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: CHEBI:79699

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: CHEBI:79699

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:79699

object_name: endometrial serous adenocarcinoma


subject: CHEBI:79699

object_name: ovarian seromucinous carcinoma


subject: CHEBI:79699

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: CHEBI:79699

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:79699

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:79699

object_name: Recurrent Pancreatic Neuroendocrine Carcinoma


subject: CHEBI:79699

object_name: carcinosarcoma of the corpus uteri